1000573-99-8

Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-3-chloro-2-nitroaniline is used as an intermediate in the synthesis of various pharmaceuticals for its ability to be chemically modified to produce a range of medicinal compounds.
Used in Dye Industry:
In the dye industry, 4-Bromo-3-chloro-2-nitroaniline is used as an intermediate to produce dyes that impart color to various materials, taking advantage of its chemical structure to create stable and vibrant dyes.
Used in Agricultural Chemicals:
4-Bromo-3-chloro-2-nitroaniline is used as a component in the development of agricultural chemicals, contributing to the creation of effective products for crop protection and enhancement.
Used in Organic Pigments Manufacturing:
4-Bromo-3-chloro-2-nitroaniline is utilized in the manufacturing of organic pigments, where its chemical properties allow for the production of pigments with specific color characteristics and stability.
Used as a Reagent in Chemical Reactions:
4-Bromo-3-chloro-2-nitroaniline serves as a reagent in various chemical reactions, facilitating specific transformations and syntheses in the laboratory and industrial settings.

Upstream product

• 59483-54-4 3-chloro-2-nitro-aniline 
• 4771-47-5 3-chloro-2-nitro-benzoic acid 

Downstream Products

• 1008361-80-5 4-bromo-3-chloro-benzene-1,2-diamine 
• 1078728-17-2 methyl 3,4-diamino-2-chlorobenzoate 
• 1357159-31-9 4-bromo-3-chloro-N-methyl-2-nitroaniline 
• 1357159-32-0 4-bromo-3-chloro-N₁-methylbenzene-1,2-diamine 
• 1357158-78-1 1-(4-(1-methyl-5-phenyl-1H-benzo[d]imidazol-4-yl)phenyl)cyclobutanamine 
• 1357159-34-2 4-chloro-1-methyl-5-phenyl-1H-benzo[d]imidazole 

Relevant academic research and scientific papers

BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING

A compound of formula (I); wherein: W is O or NH; A1 1 is CRAA or N; A22 is CRBB or N; A3A3 is CRCC or N; A44 is CRDD or N; where no more than two of A11, A

PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS

The invention provides new pyrazine derivatives of formula (I): or a tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein. The invention also provides pharmaceutical compositions comprising sa

HETEROBICYCLIC COMPOUNDS FOR INHIBITING THE ACTIVITY OF SHP2

A compound of formula (I):wherein Ring A, Q, R1,R2, R3, R4, R5, R6, R7, R8, R9, R10, R11,X, a,b, c and d are as defined in the specification.

PHARMACEUTICAL COMPOUNDS

The invention provides new pyrazine derivatives of formula (I), or a tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein. The invention also provides pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS

Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I" and I'" or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.

COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS

Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula (I), or a pharmaceutically acceptable salt or composition thereof The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduce the excessive activation of complement.

NRF2 REGULATORS

The present invention relates to bis aryl analogs, pharmaceutical compositions containing them and their use as Nrf2 regulators.

ANTI-VIRAL COMPOUNDS

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF

The present application relates to novel substituted 5-aminopyrazoles, methods of production thereof, use thereof alone or in combinations for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases.